This invention relates to chemically modified cellulosic fibres and processes for making nonwoven fibre webs from them. In particular it relates to chemically modified cellulosic fibres which may be carded on a carding machine to produce a web. The fibres may be ultimately processed into nonwoven fabrics for instance by needling or entangling the web, the fabrics being suitable for use in absorbent personal products or absorbent medical products such as wound dressings. Also described are carding processes suitable for forming webs of chemically modified cellulosic fibres or blends of chemically modified fibres with other non-gelling fibres, for example viscose or Tencel or other cellulosic fibres.
Absorbent cellulosic fibres are well known. For instance GB-A-2220881 and GB-A-2094802 describe the production of carboxymethyl cellulose fibres from regenerated cellulose fibres (viscose rayon) fibres or from cotton. Itis also known that carboxymethyl cellulose fibre of greater absorbency and strength can be produced from solvent-spun cellulose fibre. Such fibres are described in EP 0616650 and are manufactured by reacting solvent spun cellulose fibre with a strong alkali and a monochloroacetic acid reagent. It is also known that alternative chemical modification of cellulose fibres is possible and also has the effect of increasing the absorbency of the cellulose fibre. The cellulose fibre can for instance be modified by sulphonation, for example by substitution with an alkyl sulphonate at one or more of the hydroxyl groups on the anhydroglucose monomers that make up the cellulose backbone forming ether linkages. Modified cellulose of this type is known as cellulose sulphonate or cellulose alkyl sulphonate some of the insoluble forms of which are described in WO2012/061225.
Modifying the cellulose fibre requires the fibre to be exposed to one or more reagents which modify the cellulose by substitution, the degree of substitution determining the absorbency and solubility of the fibre. As the degree of substitution is increased the modified cellulose becomes increasingly soluble. As the solubility increases, absorbency also increases.
For some applications, for instance for absorbent gelling wound dressings, the chemically modified fibres need to be insoluble and retain some of their fibrous form when exposed to wound fluid and consequently a balance needs to be found between solubility and absorbency. The chemically modified fibre can be in the form of a tow, filament, sliver, yarn or staple fibre, woven, non-woven or knitted fabric.
Once the modification and neutralisation in acid has taken place, the fibres need to be washed to remove any unreacted alkali, chloroacetate, alkylsulphonate, other modifying agent or any by-products such as sodium chloride or sodium glycollate. An aqueous wash is generally used initially, preferably a mixture of water with a water-miscible organic solvent such as water and IMS, the major portion of the wash being organic solvent. The wash may contain an organic hydroxyl compound, a surfactant, and/or acid. The organic hydroxyl compound is a compound containing at least one alcoholic hydroxyl group, for example ethanol, methanol or another low molecular weight alcohol and/or a compound such as ethylene glycol or propylene glycol.
The final wash or finish typically comprises a large percentage of alcohol for instance, 99% industrial alcohol and 1% emulsifier or 100% alcohol. After washing, the fibres are dried at low temperature for instance as described in EP 0680344, by forced air drying or radiant heat drying.
As the washing step or steps to which the fibres are subjected following modification involve the use of relatively high percentages of organic solvents such as industrial alcohol, the drying of the fibres requires the solvents that are released to be managed from an environmental and safety perspective. It would be desirable to reduce the percentage of organic solvents used in the washing process so that environmental and safety standards can be readily met. There are also potential cost and efficiency advantages to using a lower percentage of organic solvents as the cost of materials and duty are reduced.
We have found that reducing, for instance, the percentage of organic solvent in the wash liquor used to wash modified cellulose fibres results in fibres that have a lower tensile strength making them less suitable for processing on textile machinery such as a carding machine. The lower tensile strength can lead to the problem of fibre breakage on carding which gives higher levels of airborne lint or dust (fly) and greater shedding of broken fibre from the finished fabric. The higher level of fly necessitates increased cleaning and environment management in the fabric production process which in turn increases cost. There is also more wastage in the process as fibres tend to drop out of the fabric during the process of manufacture.
Fibre breakage can also adversely affect the staple length which has the effect of reducing the strength of a carded web and nonwoven fabric made from the fibres. It is possible that fibre breakage leads to a failed card process where no non-woven mat is produced. A weaker product can be more difficult to remove from the wound as the integrity of the dressing can be compromised.
We have now found that it is possible to mitigate the problem of low tensile strength in modified fibres by controlled management of the moisture content of the fibres.
Accordingly the invention provides a chemically modified cellulosic web of fibres having a tensile strength of at least 3N per cm (N/cm) in the cross direction produced by processing fibres having a moisture content of at least 7% by weight.
Controlling the moisture content of the fibres, either by controlling the drying process following washing of the modified fibres as part of the chemical modification process or by conditioning the fibres to increase their moisture content to at least 7% subsequent to drying, increases the tensile strength of the fibres to the point where it is possible to process the fibres for example on a carding machine to produce a non-woven fibre web without the production of excessive fly or shedding from a fabric produced from the web. Preferably the moisture content of the fibres is kept at between 11 and 20% by controlling the drying process following washing of the modified fibres as part of the chemical modification process.
Preferably the tensile strength is measured in the cross direction on needled webs having a basis weight in the range of 80 to 120 gsm.
Accordingly the invention provides, in a further aspect, a process for producing a non-woven web of chemically modified cellulosic fibres comprising the steps of:
The fibres are typically those resulting from a modification process using a wash or final rinse comprising less than 99% by weight such as 95% by weight of organic solvent in the wash liquor. By controlling the moisture content, the fibres can be processed into a consolidated form that allows a fabric to be produced by conventional carding means while mitigating the problem of fibre breakage and fly in the environment of the fabric production plant. A consolidated form could for example be a yarn, sliver, woven, non-woven or knitted fabric.
When the fibres are to be processed using textiling machinery, if it is found that the moisture content of the fibres is too low, the moisture content of the modified cellulosic fibres is increased by exposing the fibres to a moisture rich environment for at least 24 hours. Alternatively the drying of the fibres at the end of the chemical modification process can be controlled so that the moisture content of the fibres is maintained above 7% until the fibres are subjected to further processing such as with textiling machinery for instance by carding and needling.
Preferably the carded, needled fibre web has a tensile strength of from 3N/cm to 25N/cm, more preferably from 7N/cm to 25N/cm and most preferably from 10N/cm to 25N/cm.
The tensile strength of the carded, needled web is measured by cutting five specimens to a size of 25 mm×75 mm with the long dimension being in the direction to be tested. Tensile testing is carried out at a gauge length (effective test fabric length) of 50 mm. One end of the sample is fixed in an upper jaw of a tensile testing machine and allowed to dangle into the lower jaw. The sample is then fixed by closing the jaws without stretching the sample or allowing it to be slack. The crosshead speed is set to 100 mm/min and the sample pulled to break. The tensile strength is calculated by dividing the force at break by the sample width in cm.
Preferably the moisture content of the fibres prior to processing with textiling machinery is from 7% to 20% by weight and more preferably from 11% to 18%. More preferably the moisture content is from 11.5% and 15% by weight and most preferably it is between 12 and 15% by weight. A moisture content of 12.5% to 15% is particularly preferred and 15% is most preferred.
By the term moisture content is meant the amount of moisture (measured by weight) contained in the sample of fibres as a percentage of its conditioned weight and measured by the loss on drying.
The moisture content of the fibres is measured by calculating the loss on drying using a moisture balance operated in accordance with the instrument manual. For convenience, during the process for making the fibres, comparative measurements of moisture content can be made using a moisture meter for instance an Aquaboy (TEMI).
By the term carding in the present invention is meant a mechanical process that disentangles, cleans and intermixes fibres to produce a continuous web or sliver suitable for further processing.
In a further aspect of the invention, the invention provides a chemically modified cellulosic fibre having a moisture content of at least 7% by weight.
The invention will now be illustrated by the following examples.
Comparison of the moisture content of fibres vs their tensile strengths once carded and needled was made by measuring the initial moisture content of dried modified cellulosic fibres produced using washes of varying alcohol content. That initial moisture content was then increased by conditioning the fibres in a moist atmosphere for 24 hours at a relative humidity of 55 to 60% and the tensile strength of the needled fabric measured again.
The results show that the moisture content of the fibres influences the tensile strength of the resulting carded and needled web. The column headed IDA in the table of
Effect of moisture content on the tensile strength of silver containing wound dressings.
Dressings were prepared by modification of solvent spun cellulose tow to a degree of substitution of 0.3 to form carboxymethylcellulose, neutralising to a pH of 5.5 with an organic acid. Adding 1.2% cationic silver by an ion exchange process in a largely organic solvent such as by the process described in Ep1343510, washing in an aqueous organic solution containing sodium chloride and di-sodium EDTA for light stabilisation and to entrain approximately 0.4% EDTA. Followed by washing in organic solvent wash containing fibre finishing agents including tween 20 and benzethonium chloride (to give 0.135% wt/wt BeCl on the finished product) and subsequently warm air drying, cutting to staple and processing into a nonwoven felt by carding and a needle punching process. The dressings were cut to size from the web and packaged in a light, moisture and vapour impermeable heat sealed foil pouch.
The dressings were removed from the packs and then subjected to various controlled environments.
Controlled Environments
Samples (ambient as packed) were tested immediately after opening the packs. Samples removed from the other environments were sealed into plastic bags during removal, and then tested immediately. The plastic bags (also preconditioned in corresponding controlled environments) were used to maintain the humidity of the environment of the samples until the point of testing.
Loss on Drying CLOD)
LOD of the samples was determined using the Ohaus moisture balance MB23 operated in accordance with the instruction manual. A sample mass of greater than 1 gram was used. Samples were cut to fit within the weighing pan, ensuring there was adequate clearance from the heating element. A standardised method was used with a maximum temperature limit of 110° C. The endpoint was determined automatically when the sample mass stopped reducing and was stable. Under these conditions the fabric did not char. Typically, samples would be subjected to a 10 minute cycle.
Fabric Thickness (Loft)
Samples were tested using the Hampden Soft Materials Thickness Gauge, Model FMTml-4D, S/N 14082. Fabric thickness (sometimes referred to as loft) was determined for 6 dressings per batch.
Fabric Dry Tensile Strength
2.5 cm×7.5 cm rectangular strips were cut from along the length (machine direction) and across the width (transverse direction) using a ribbon cutting die and press. Samples were conditioned as described Table 1. The peak force and the extension at which that force occurred were recorded when a 50 mm test length was stretched at a constant separation rate of 100 mm per minute.
Loss on drying is the summation of all the volatile substances that can be removed by heating at 110° C. These include ethanol, water and to some degree acetic acid.
For this particular fibre, for this example, textile trials have shown that fibres for use in wound dressings according to the invention can be successfully textiled between 42% and 50% RH at around 18 to 20° C. Trials suggest that fibres with 10.5% to 11.5% w/w moisture content can be carded efficiently.
The results show that tensile strength, loft and LOD are all functions of equilibrium moisture content. The results suggest that fibres with a moisture content of greater than 9% will be able to be textiled to produce dressings suitable for use in the present invention.
Materials
Two gelling fibre types were used in this study; cellulose ethylsulphonate (CES) and carboxymethyl cellulose (CMC).
Methods
Single fibres were mounted onto card windows as described in BS EN 5079:1996.
In addition, tow bundles were prepared to assess the moisture content.
Fibres were oven dried at 105° C. for one hour prior to being conditioned at the chosen relative humidity for a minimum of 16 hours. The mass of the oven dried tow bundles (W1) and the conditioned tow bundles (W2) was taken to assess the moisture content of the fibres, using Equation 1.
Single fibre tensile strength of the conditioned samples was undertaken using the method described in BS EN 5079:1996.
Fibres were tested at 45% RH, 65% RH, and 85% RH.
Results
Results found that a significantly higher (P≤0.05) tensile strength was seen in the samples conditioned at 65% RH than those conditioned at 45% RH and 85% RH as shown in Table 2.
Number | Date | Country | Kind |
---|---|---|---|
1223408 | Dec 2012 | GB | national |
1308774 | May 2013 | GB | national |
This application is a continuation of U.S. patent application Ser. No. 14/654,498 filed Jun. 19, 2015, which is a U.S. National Phase application of International Patent Application Serial No. PCT/GB2013/053374 filed Dec. 20, 2013, which claims priority to Great Britain Patent Application Serial No. 1223408.4 filed Dec. 20, 2012, and Great Britain Patent Application Serial No. 1308774.7 filed May 15, 2013, the contents of each application are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2396514 | Kreidl et al. | Mar 1946 | A |
2785106 | Mendelson | Mar 1957 | A |
3061469 | Manowitz et al. | Oct 1962 | A |
3092552 | Romans | Jun 1963 | A |
4258056 | Lentsch | Mar 1981 | A |
4344324 | Langer | Aug 1982 | A |
4612337 | Fox, Jr. et al. | Sep 1986 | A |
4655758 | Ring et al. | Apr 1987 | A |
4728323 | Matson | Mar 1988 | A |
4829129 | Kelley | May 1989 | A |
4889654 | Mason et al. | Dec 1989 | A |
4906100 | Rice et al. | Mar 1990 | A |
4973848 | Kolobanov et al. | Nov 1990 | A |
5064652 | Bay | Nov 1991 | A |
5326567 | Capelli | Jul 1994 | A |
5340924 | Tomita et al. | Aug 1994 | A |
5407656 | Roozdar | Apr 1995 | A |
5527534 | Myhling | Jun 1996 | A |
5567495 | Modak et al. | Oct 1996 | A |
5616347 | Alliger et al. | Apr 1997 | A |
5662913 | Capelli | Sep 1997 | A |
5709870 | Yoshimura et al. | Jan 1998 | A |
5731083 | Bahia et al. | Mar 1998 | A |
5744151 | Capelli | Apr 1998 | A |
5744155 | Friedman et al. | Apr 1998 | A |
5762620 | Cartmell et al. | Jun 1998 | A |
5820918 | Ronan et al. | Oct 1998 | A |
5848995 | Walder | Dec 1998 | A |
5860947 | Stamler | Jan 1999 | A |
5998488 | Shinohara et al. | Dec 1999 | A |
6075177 | Bahia | Jun 2000 | A |
6207601 | Maurer et al. | Mar 2001 | B1 |
6238691 | Huang | May 2001 | B1 |
6290496 | Azar et al. | Sep 2001 | B1 |
6413556 | Bathurst et al. | Jul 2002 | B1 |
6468965 | Cutler | Oct 2002 | B1 |
6548730 | Patel et al. | Apr 2003 | B1 |
6555508 | Paul et al. | Apr 2003 | B1 |
6605751 | Gibbins et al. | Aug 2003 | B1 |
6669981 | Parsons et al. | Dec 2003 | B2 |
6750262 | Haehnle et al. | Jun 2004 | B1 |
6753063 | Pung et al. | Jun 2004 | B1 |
7033511 | Zawada et al. | Apr 2006 | B2 |
7267828 | Parsons et al. | Sep 2007 | B2 |
8637072 | Kershaw et al. | Jan 2014 | B2 |
9149035 | Percival et al. | Oct 2015 | B2 |
10016537 | Menon et al. | Jul 2018 | B2 |
10046096 | Askem et al. | Aug 2018 | B2 |
10076447 | Barta et al. | Sep 2018 | B2 |
10076587 | Locke et al. | Sep 2018 | B2 |
10143784 | Walton et al. | Dec 2018 | B2 |
10426670 | von Blucher et al. | Oct 2019 | B2 |
10426747 | Johnson | Oct 2019 | B2 |
10426874 | Chien et al. | Oct 2019 | B2 |
10426875 | Blott et al. | Oct 2019 | B2 |
10426938 | Locke et al. | Oct 2019 | B2 |
10434015 | Taylor et al. | Oct 2019 | B2 |
10434142 | Niazi et al. | Oct 2019 | B2 |
10434210 | Olson et al. | Oct 2019 | B2 |
10434284 | Hanson et al. | Oct 2019 | B2 |
10449094 | Donda et al. | Oct 2019 | B2 |
D866756 | Allen et al. | Nov 2019 | S |
10463760 | Karthikeyan et al. | Nov 2019 | B2 |
10463773 | Haggstrom et al. | Nov 2019 | B2 |
10470933 | Riesinger | Nov 2019 | B2 |
10470936 | Wohlgemuth et al. | Nov 2019 | B2 |
10471122 | Shi et al. | Nov 2019 | B2 |
10471190 | Locke et al. | Nov 2019 | B2 |
10478345 | Barta et al. | Nov 2019 | B2 |
10478346 | Knutson | Nov 2019 | B2 |
10478394 | Yu | Nov 2019 | B2 |
10485707 | Sexton | Nov 2019 | B2 |
10485891 | Andrews et al. | Nov 2019 | B2 |
10485892 | Hands et al. | Nov 2019 | B2 |
10485906 | Freedman et al. | Nov 2019 | B2 |
10486135 | Yang et al. | Nov 2019 | B2 |
10492956 | Zamierowski | Dec 2019 | B2 |
10493178 | Marchant et al. | Dec 2019 | B2 |
10493184 | Collinson et al. | Dec 2019 | B2 |
10493185 | Stokes et al. | Dec 2019 | B2 |
10500099 | Hung et al. | Dec 2019 | B2 |
10500103 | Croizat et al. | Dec 2019 | B2 |
10500104 | Sookraj | Dec 2019 | B2 |
10500173 | Yang et al. | Dec 2019 | B2 |
10500235 | Wardell | Dec 2019 | B2 |
10500300 | Dybe et al. | Dec 2019 | B2 |
10500301 | Laurensou | Dec 2019 | B2 |
10500302 | Holm et al. | Dec 2019 | B2 |
10501487 | Andrews et al. | Dec 2019 | B2 |
10506928 | Locke et al. | Dec 2019 | B2 |
10507141 | Allen et al. | Dec 2019 | B2 |
10507259 | Cree et al. | Dec 2019 | B2 |
10512707 | Whalen, III et al. | Dec 2019 | B2 |
10525170 | Havenstrite et al. | Jan 2020 | B2 |
10532137 | Pratt et al. | Jan 2020 | B2 |
10532194 | Locke et al. | Jan 2020 | B2 |
10537657 | Phillips et al. | Jan 2020 | B2 |
10542936 | Goldberg et al. | Jan 2020 | B2 |
10543133 | Shaw et al. | Jan 2020 | B2 |
10543293 | Suschek | Jan 2020 | B2 |
10548777 | Locke et al. | Feb 2020 | B2 |
10549008 | Yoo | Feb 2020 | B2 |
10549016 | Bushko et al. | Feb 2020 | B2 |
10549017 | Hsiao et al. | Feb 2020 | B2 |
10555838 | Wu et al. | Feb 2020 | B2 |
10555839 | Hartwell | Feb 2020 | B2 |
10556044 | Robinson et al. | Feb 2020 | B2 |
10561533 | Hoggarth et al. | Feb 2020 | B2 |
10561536 | Holm et al. | Feb 2020 | B2 |
10568767 | Addison et al. | Feb 2020 | B2 |
10568768 | Long et al. | Feb 2020 | B2 |
10568770 | Robinson et al. | Feb 2020 | B2 |
10568771 | MacDonald et al. | Feb 2020 | B2 |
10568773 | Tuck et al. | Feb 2020 | B2 |
10568983 | Gerdes et al. | Feb 2020 | B2 |
10575991 | Dunn | Mar 2020 | B2 |
10575992 | Sarangapani et al. | Mar 2020 | B2 |
10576037 | Harrell | Mar 2020 | B2 |
10576189 | Locke et al. | Mar 2020 | B2 |
10583042 | Sarangapani et al. | Mar 2020 | B2 |
10583228 | Shuler et al. | Mar 2020 | B2 |
10589007 | Coulthard et al. | Mar 2020 | B2 |
10590184 | Kuo | Mar 2020 | B2 |
10610414 | Hartwell et al. | Apr 2020 | B2 |
10610415 | Griffey et al. | Apr 2020 | B2 |
10610623 | Robinson et al. | Apr 2020 | B2 |
10617569 | Bonn | Apr 2020 | B2 |
10617608 | Shin et al. | Apr 2020 | B2 |
10617769 | Huang | Apr 2020 | B2 |
10617784 | Yu et al. | Apr 2020 | B2 |
10617786 | Kluge et al. | Apr 2020 | B2 |
10618266 | Wright et al. | Apr 2020 | B2 |
10624984 | Courage et al. | Apr 2020 | B2 |
10625002 | Locke et al. | Apr 2020 | B2 |
10632019 | Vitaris | Apr 2020 | B2 |
10632224 | Hardy et al. | Apr 2020 | B2 |
10639206 | Hu et al. | May 2020 | B2 |
10639350 | Arber et al. | May 2020 | B2 |
10639404 | Lichtenstein | May 2020 | B2 |
10646614 | Grinstaff et al. | May 2020 | B2 |
10653562 | Robinson et al. | May 2020 | B2 |
10653782 | Ameer et al. | May 2020 | B2 |
10653810 | Datt et al. | May 2020 | B2 |
10653821 | Nichols | May 2020 | B2 |
10653823 | Bharti et al. | May 2020 | B2 |
10660799 | Wu et al. | May 2020 | B2 |
10660851 | Millis et al. | May 2020 | B2 |
10660992 | Canner et al. | May 2020 | B2 |
10660994 | Askem et al. | May 2020 | B2 |
10667955 | Allen et al. | Jun 2020 | B2 |
10667956 | Van Holten et al. | Jun 2020 | B2 |
10682257 | Lu | Jun 2020 | B2 |
10682258 | Manwaring et al. | Jun 2020 | B2 |
10682259 | Hunt et al. | Jun 2020 | B2 |
10682318 | Twomey et al. | Jun 2020 | B2 |
10682386 | Ellis-Behnke et al. | Jun 2020 | B2 |
10682446 | Askem et al. | Jun 2020 | B2 |
10687983 | Dahlberg et al. | Jun 2020 | B2 |
10687985 | Lee et al. | Jun 2020 | B2 |
10688215 | Munro et al. | Jun 2020 | B2 |
10688217 | Hanson et al. | Jun 2020 | B2 |
RE48117 | Albert et al. | Jul 2020 | E |
10702419 | Locke et al. | Jul 2020 | B2 |
10702420 | Hammond et al. | Jul 2020 | B2 |
10703942 | Tunius | Jul 2020 | B2 |
10709760 | Gronberg et al. | Jul 2020 | B2 |
10709807 | Kshirsagar | Jul 2020 | B2 |
10709883 | Spector | Jul 2020 | B2 |
10716711 | Locke et al. | Jul 2020 | B2 |
10716874 | Koyama et al. | Jul 2020 | B2 |
10729589 | Dorian et al. | Aug 2020 | B2 |
10729590 | Simmons et al. | Aug 2020 | B2 |
10729826 | Lin | Aug 2020 | B2 |
10736787 | Hannigan et al. | Aug 2020 | B2 |
10736788 | Locke et al. | Aug 2020 | B2 |
10736985 | Odermatt et al. | Aug 2020 | B2 |
10737003 | Fujisaki | Aug 2020 | B2 |
10743900 | Ingram et al. | Aug 2020 | B2 |
10744040 | Kazala, Jr. et al. | Aug 2020 | B2 |
10744041 | Hartwell | Aug 2020 | B2 |
10744225 | Lindgren et al. | Aug 2020 | B2 |
10744237 | Guidi et al. | Aug 2020 | B2 |
10744238 | Guidi et al. | Aug 2020 | B2 |
10744239 | Armstrong et al. | Aug 2020 | B2 |
10744240 | Simmons et al. | Aug 2020 | B2 |
10751212 | Raza et al. | Aug 2020 | B2 |
10751442 | Bonnefin et al. | Aug 2020 | B2 |
10751452 | Topaz | Aug 2020 | B2 |
10758423 | Pigg et al. | Sep 2020 | B2 |
10758424 | Blott et al. | Sep 2020 | B2 |
10758425 | Blott et al. | Sep 2020 | B2 |
10758426 | Eddy | Sep 2020 | B2 |
10758651 | Blott et al. | Sep 2020 | B2 |
10765561 | Lattimore et al. | Sep 2020 | B2 |
10765783 | Locke et al. | Sep 2020 | B2 |
10772767 | Bjork et al. | Sep 2020 | B2 |
10772999 | Svensby | Sep 2020 | B2 |
10779993 | Bishop et al. | Sep 2020 | B2 |
10780114 | Udagawa et al. | Sep 2020 | B2 |
10780194 | Flach et al. | Sep 2020 | B2 |
10780201 | Lin | Sep 2020 | B2 |
10780202 | Askem et al. | Sep 2020 | B2 |
10780203 | Coulthard et al. | Sep 2020 | B2 |
10782238 | Hicks et al. | Sep 2020 | B2 |
10792191 | Robinson et al. | Oct 2020 | B2 |
10792192 | Tout et al. | Oct 2020 | B2 |
10792337 | Leung et al. | Oct 2020 | B2 |
10792404 | Hu et al. | Oct 2020 | B2 |
10792482 | Randolph et al. | Oct 2020 | B2 |
10800905 | Delli-Santi et al. | Oct 2020 | B2 |
10806819 | Shuler | Oct 2020 | B2 |
20020091074 | Wooley et al. | Jul 2002 | A1 |
20020160941 | Kruzel | Oct 2002 | A1 |
20020172709 | Nielsen et al. | Nov 2002 | A1 |
20020183808 | Biel | Dec 2002 | A1 |
20030180345 | Hill et al. | Sep 2003 | A1 |
20030180346 | Woods | Sep 2003 | A1 |
20040001880 | Bowler et al. | Jan 2004 | A1 |
20040247652 | Sabesan | Dec 2004 | A1 |
20050059731 | Albrecht et al. | Mar 2005 | A1 |
20060019571 | Lange et al. | Jan 2006 | A1 |
20060051385 | Scholz | Mar 2006 | A1 |
20060051430 | Arata et al. | Mar 2006 | A1 |
20060115440 | Arata et al. | Jun 2006 | A1 |
20060155260 | Blott et al. | Jul 2006 | A1 |
20060172000 | Cullen et al. | Aug 2006 | A1 |
20060234959 | Biel et al. | Oct 2006 | A1 |
20060254988 | Frampton | Nov 2006 | A1 |
20070042024 | Gladman et al. | Feb 2007 | A1 |
20070134136 | Polyakov et al. | Jun 2007 | A1 |
20070166399 | Burton et al. | Jul 2007 | A1 |
20070185426 | Ambrosio et al. | Aug 2007 | A1 |
20070219512 | Heaton et al. | Sep 2007 | A1 |
20070239078 | Jaeb | Oct 2007 | A1 |
20070255192 | Patel et al. | Nov 2007 | A1 |
20080112920 | Chia et al. | May 2008 | A1 |
20080188558 | Godal et al. | Aug 2008 | A1 |
20080226724 | Ji et al. | Sep 2008 | A1 |
20090012440 | Bray et al. | Jan 2009 | A1 |
20090177135 | Rogers et al. | Jul 2009 | A1 |
20090234307 | Vitaris | Sep 2009 | A1 |
20090259203 | Hu et al. | Oct 2009 | A1 |
20090293887 | Wilkes et al. | Dec 2009 | A1 |
20090299303 | Seegert | Dec 2009 | A1 |
20100015208 | Kershaw et al. | Jan 2010 | A1 |
20100030178 | MacMeccan et al. | Feb 2010 | A1 |
20100113537 | Nonaka | May 2010 | A1 |
20100125233 | Edward S. et al. | May 2010 | A1 |
20100125258 | Coulthard et al. | May 2010 | A1 |
20100129633 | Law | May 2010 | A1 |
20100137775 | Hu et al. | Jun 2010 | A1 |
20100185163 | Heagle | Jul 2010 | A1 |
20100298790 | Guidi et al. | Nov 2010 | A1 |
20100310845 | Bond et al. | Dec 2010 | A1 |
20110015595 | Robinson et al. | Jan 2011 | A1 |
20110028918 | Hartwell | Feb 2011 | A1 |
20110112457 | Holm et al. | May 2011 | A1 |
20110117025 | Dacosta et al. | May 2011 | A1 |
20110178451 | Robinson et al. | Jul 2011 | A1 |
20110224593 | Tunius | Sep 2011 | A1 |
20110224630 | Simmons et al. | Sep 2011 | A1 |
20110230849 | Coulthard et al. | Sep 2011 | A1 |
20110237994 | Russ et al. | Sep 2011 | A1 |
20110251566 | Zimnitsky et al. | Oct 2011 | A1 |
20110257572 | Locke et al. | Oct 2011 | A1 |
20110257573 | Hong et al. | Oct 2011 | A1 |
20110275972 | Rosenberg | Nov 2011 | A1 |
20110319808 | Bowler et al. | Dec 2011 | A1 |
20120071845 | Hu et al. | Mar 2012 | A1 |
20120130332 | Cotton et al. | May 2012 | A1 |
20120136325 | Allen et al. | May 2012 | A1 |
20120202398 | Marshall et al. | Aug 2012 | A1 |
20120209226 | Simmons et al. | Aug 2012 | A1 |
20120232502 | Lowing | Sep 2012 | A1 |
20130053795 | Coulthard et al. | Feb 2013 | A1 |
20130123728 | Pratt et al. | May 2013 | A1 |
20130226063 | Taylor et al. | Aug 2013 | A1 |
20140005618 | Locke et al. | Jan 2014 | A1 |
20140074053 | Locke et al. | Mar 2014 | A1 |
20140188060 | Robinson et al. | Jul 2014 | A1 |
20140194838 | Wibaux et al. | Jul 2014 | A1 |
20140200532 | Robinson et al. | Jul 2014 | A1 |
20140236112 | Von Wolff et al. | Aug 2014 | A1 |
20140256925 | Catchmark et al. | Sep 2014 | A1 |
20140276499 | Locke et al. | Sep 2014 | A1 |
20140296804 | Hicks et al. | Oct 2014 | A1 |
20140308338 | Nierle et al. | Oct 2014 | A1 |
20140309574 | Cotton | Oct 2014 | A1 |
20150018433 | Leipzig et al. | Jan 2015 | A1 |
20150057624 | Simmons et al. | Feb 2015 | A1 |
20150071985 | Walker et al. | Mar 2015 | A1 |
20150079152 | Wuollett et al. | Mar 2015 | A1 |
20150094674 | Pratt et al. | Apr 2015 | A1 |
20150104486 | Bonnefin et al. | Apr 2015 | A1 |
20150112311 | Hammond et al. | Apr 2015 | A1 |
20150119831 | Robinson et al. | Apr 2015 | A1 |
20150119834 | Locke et al. | Apr 2015 | A1 |
20150141941 | Allen et al. | May 2015 | A1 |
20150148785 | Kleiner | May 2015 | A1 |
20150174304 | Askem et al. | Jun 2015 | A1 |
20150245949 | Locke et al. | Sep 2015 | A1 |
20150246164 | Heaton et al. | Sep 2015 | A1 |
20150250979 | Loske | Sep 2015 | A1 |
20150265741 | Duncan et al. | Sep 2015 | A1 |
20150265743 | Hanson et al. | Sep 2015 | A1 |
20150320901 | Chandrashekhar-Bhat et al. | Nov 2015 | A1 |
20160008293 | Shi et al. | Jan 2016 | A1 |
20160038626 | Locke et al. | Feb 2016 | A1 |
20160051724 | Sahin et al. | Feb 2016 | A1 |
20160067107 | Cotton | Mar 2016 | A1 |
20160100987 | Hartwell et al. | Apr 2016 | A1 |
20160101207 | Parsons et al. | Apr 2016 | A1 |
20160106878 | Yang et al. | Apr 2016 | A1 |
20160106892 | Hartwell | Apr 2016 | A1 |
20160166422 | Karim et al. | Jun 2016 | A1 |
20160193244 | Ota et al. | Jul 2016 | A1 |
20160222548 | Agboh | Aug 2016 | A1 |
20160271178 | Hauser et al. | Sep 2016 | A1 |
20160287743 | Andrews | Oct 2016 | A1 |
20160339158 | Collinson et al. | Nov 2016 | A1 |
20160374847 | Lachenbruch et al. | Dec 2016 | A1 |
20170014275 | Schneider | Jan 2017 | A1 |
20170049111 | Patton et al. | Feb 2017 | A1 |
20170072669 | Sekido et al. | Mar 2017 | A1 |
20170079276 | Percival et al. | Mar 2017 | A1 |
20170128269 | Coulthard et al. | May 2017 | A1 |
20170189237 | Locke et al. | Jul 2017 | A1 |
20170189575 | Lee et al. | Jul 2017 | A1 |
20170209615 | Tornero Garcia et al. | Jul 2017 | A1 |
20170232161 | Fewkes et al. | Aug 2017 | A1 |
20170258956 | Flach et al. | Sep 2017 | A1 |
20170347661 | Parsons | Dec 2017 | A1 |
20170367895 | Holm et al. | Dec 2017 | A1 |
20170368239 | Askem et al. | Dec 2017 | A1 |
20180008742 | Hoggarth et al. | Jan 2018 | A1 |
20180014974 | Hoggarth et al. | Jan 2018 | A1 |
20180023217 | Patton et al. | Jan 2018 | A1 |
20180030321 | Tunius | Feb 2018 | A1 |
20180042789 | Bradford et al. | Feb 2018 | A1 |
20180078423 | Magin et al. | Mar 2018 | A1 |
20180086903 | Zhang et al. | Mar 2018 | A1 |
20180118809 | Mearns Spragg | May 2018 | A1 |
20180133066 | Ahsani et al. | May 2018 | A1 |
20180140467 | Hunt | May 2018 | A1 |
20180140822 | Robinson et al. | May 2018 | A1 |
20180200414 | Askem et al. | Jul 2018 | A1 |
20180221531 | Bender et al. | Aug 2018 | A1 |
20180236124 | Young et al. | Aug 2018 | A1 |
20180243463 | Chatterjee et al. | Aug 2018 | A1 |
20180243464 | Hwang et al. | Aug 2018 | A1 |
20180244857 | Lee et al. | Aug 2018 | A1 |
20180272052 | Locke et al. | Sep 2018 | A1 |
20180296397 | Askem et al. | Oct 2018 | A1 |
20180303873 | Been et al. | Oct 2018 | A1 |
20180311419 | Locke et al. | Nov 2018 | A1 |
20180333522 | Pratt et al. | Nov 2018 | A1 |
20180344533 | Rovaniemi | Dec 2018 | A1 |
20180353334 | Locke et al. | Dec 2018 | A1 |
20180353337 | Locke | Dec 2018 | A1 |
20180353339 | Locke et al. | Dec 2018 | A1 |
20180353340 | Robinson et al. | Dec 2018 | A1 |
20180353344 | Locke et al. | Dec 2018 | A1 |
20180353662 | Locke et al. | Dec 2018 | A1 |
20180353663 | Locke et al. | Dec 2018 | A1 |
20180360667 | Droche | Dec 2018 | A1 |
20190000677 | Munro | Jan 2019 | A1 |
20190015258 | Gowans et al. | Jan 2019 | A1 |
20190015468 | Yadav et al. | Jan 2019 | A1 |
20190030223 | Lin | Jan 2019 | A1 |
20190046682 | Choi et al. | Feb 2019 | A1 |
20190060127 | Locke et al. | Feb 2019 | A1 |
20190083752 | Howell et al. | Mar 2019 | A1 |
20190117465 | Osborne et al. | Apr 2019 | A1 |
20190117466 | Kazala, Jr. et al. | Apr 2019 | A1 |
20190117861 | Locke et al. | Apr 2019 | A1 |
20190125590 | Rehbein et al. | May 2019 | A1 |
20190133830 | Bishop et al. | May 2019 | A1 |
20190151155 | Bonn | May 2019 | A1 |
20190151159 | Gowans et al. | May 2019 | A1 |
20190151495 | Helary et al. | May 2019 | A1 |
20190184052 | Ilan et al. | Jun 2019 | A1 |
20190231600 | Locke et al. | Aug 2019 | A1 |
20190231602 | Locke et al. | Aug 2019 | A1 |
20190231943 | Robinson et al. | Aug 2019 | A1 |
20190274889 | Steward et al. | Sep 2019 | A1 |
20190282728 | Kellar et al. | Sep 2019 | A1 |
20190290799 | Arshi et al. | Sep 2019 | A1 |
20190298249 | Bates et al. | Oct 2019 | A1 |
20190298577 | Locke et al. | Oct 2019 | A1 |
20190298578 | Shulman et al. | Oct 2019 | A1 |
20190298579 | Moore et al. | Oct 2019 | A1 |
20190298580 | Hall et al. | Oct 2019 | A1 |
20190298582 | Addison et al. | Oct 2019 | A1 |
20190298881 | Ramjit et al. | Oct 2019 | A1 |
20190298882 | Nelson | Oct 2019 | A1 |
20190298895 | Selby et al. | Oct 2019 | A1 |
20190307611 | Askem et al. | Oct 2019 | A1 |
20190307612 | Hartwell et al. | Oct 2019 | A1 |
20190307934 | Allen et al. | Oct 2019 | A1 |
20190307935 | Simmons et al. | Oct 2019 | A1 |
20190314187 | Emslander et al. | Oct 2019 | A1 |
20190314209 | Ha et al. | Oct 2019 | A1 |
20190314544 | Filho et al. | Oct 2019 | A1 |
20190321232 | Jardret et al. | Oct 2019 | A1 |
20190321509 | Chakravarthy et al. | Oct 2019 | A1 |
20190321526 | Robinson et al. | Oct 2019 | A1 |
20190322795 | Kubo et al. | Oct 2019 | A1 |
20190328580 | Emslander et al. | Oct 2019 | A1 |
20190336343 | Etchells et al. | Nov 2019 | A1 |
20190336344 | Locke | Nov 2019 | A1 |
20190336345 | Bannwart | Nov 2019 | A1 |
20190336346 | Locke et al. | Nov 2019 | A1 |
20190336640 | Vismara et al. | Nov 2019 | A1 |
20190336641 | Nisbet | Nov 2019 | A1 |
20190336643 | Luukko et al. | Nov 2019 | A1 |
20190336658 | Heaton et al. | Nov 2019 | A1 |
20190336739 | Locke et al. | Nov 2019 | A1 |
20190343687 | Locke et al. | Nov 2019 | A1 |
20190343889 | Luukko et al. | Nov 2019 | A1 |
20190343979 | Kearney et al. | Nov 2019 | A1 |
20190343993 | Weston | Nov 2019 | A1 |
20190343994 | Greener | Nov 2019 | A1 |
20190344242 | Kim et al. | Nov 2019 | A1 |
20190350763 | Pratt et al. | Nov 2019 | A1 |
20190350764 | Zochowski et al. | Nov 2019 | A1 |
20190350765 | Heagle et al. | Nov 2019 | A1 |
20190350775 | Biasutti et al. | Nov 2019 | A1 |
20190350970 | Saphier et al. | Nov 2019 | A1 |
20190351092 | Silver et al. | Nov 2019 | A1 |
20190351093 | Stein et al. | Nov 2019 | A1 |
20190351094 | Maher et al. | Nov 2019 | A1 |
20190351095 | Maher et al. | Nov 2019 | A1 |
20190351111 | Locke et al. | Nov 2019 | A1 |
20190358088 | Lavocah et al. | Nov 2019 | A1 |
20190358361 | Mcinnes et al. | Nov 2019 | A1 |
20190358372 | Askem et al. | Nov 2019 | A1 |
20190365948 | Deegan et al. | Dec 2019 | A1 |
20190365962 | Lee et al. | Dec 2019 | A1 |
20190374408 | Robles et al. | Dec 2019 | A1 |
20190374673 | Hoefinghoff et al. | Dec 2019 | A1 |
20190380878 | Edwards et al. | Dec 2019 | A1 |
20190380881 | Albert et al. | Dec 2019 | A1 |
20190380882 | Taylor et al. | Dec 2019 | A1 |
20190380883 | Macphee et al. | Dec 2019 | A1 |
20190381222 | Locke et al. | Dec 2019 | A9 |
20190388577 | Chandrashekhar-Bhat et al. | Dec 2019 | A1 |
20190388579 | Macphee et al. | Dec 2019 | A1 |
20190388589 | Macphee et al. | Dec 2019 | A1 |
20200000640 | Mondal et al. | Jan 2020 | A1 |
20200000642 | Waite | Jan 2020 | A1 |
20200000643 | Locke | Jan 2020 | A1 |
20200000955 | Andrews et al. | Jan 2020 | A1 |
20200000956 | Huang et al. | Jan 2020 | A1 |
20200000960 | Kellar et al. | Jan 2020 | A1 |
20200000985 | Seddon et al. | Jan 2020 | A1 |
20200008981 | Wheldrake | Jan 2020 | A1 |
20200009289 | Torabinejad et al. | Jan 2020 | A1 |
20200009400 | Ribeiro et al. | Jan 2020 | A1 |
20200017650 | Young et al. | Jan 2020 | A1 |
20200022844 | Blott et al. | Jan 2020 | A1 |
20200023102 | Powell | Jan 2020 | A1 |
20200023103 | Joshi et al. | Jan 2020 | A1 |
20200023104 | Eriksson et al. | Jan 2020 | A1 |
20200023105 | Long et al. | Jan 2020 | A1 |
20200023106 | Carroll et al. | Jan 2020 | A1 |
20200030153 | Johannison et al. | Jan 2020 | A1 |
20200030480 | Choi | Jan 2020 | A1 |
20200030499 | Menon et al. | Jan 2020 | A1 |
20200038023 | Dunn | Feb 2020 | A1 |
20200038249 | Pratt et al. | Feb 2020 | A1 |
20200038250 | Edwards et al. | Feb 2020 | A1 |
20200038251 | Locke et al. | Feb 2020 | A1 |
20200038252 | Spiro | Feb 2020 | A1 |
20200038283 | Hall et al. | Feb 2020 | A1 |
20200038470 | Datt et al. | Feb 2020 | A1 |
20200038544 | Grover et al. | Feb 2020 | A1 |
20200038546 | Dizio et al. | Feb 2020 | A1 |
20200038639 | Patel et al. | Feb 2020 | A1 |
20200046565 | Barta et al. | Feb 2020 | A1 |
20200046566 | Carey et al. | Feb 2020 | A1 |
20200046567 | Carroll et al. | Feb 2020 | A1 |
20200046568 | Sexton | Feb 2020 | A1 |
20200046663 | Murdock et al. | Feb 2020 | A1 |
20200046876 | Liu | Feb 2020 | A1 |
20200046887 | Runquist et al. | Feb 2020 | A1 |
20200054491 | Hentrich et al. | Feb 2020 | A1 |
20200054781 | Weiser et al. | Feb 2020 | A1 |
20200060879 | Edwards et al. | Feb 2020 | A1 |
20200061253 | Long et al. | Feb 2020 | A1 |
20200061254 | Joshi et al. | Feb 2020 | A1 |
20200061379 | Bogie et al. | Feb 2020 | A1 |
20200069183 | Rice et al. | Mar 2020 | A1 |
20200069476 | Randolph et al. | Mar 2020 | A1 |
20200069477 | Holm et al. | Mar 2020 | A1 |
20200069478 | Jabbarzadeh et al. | Mar 2020 | A1 |
20200069479 | Buan et al. | Mar 2020 | A1 |
20200069835 | Hissink et al. | Mar 2020 | A1 |
20200069850 | Beadle et al. | Mar 2020 | A1 |
20200069851 | Blott et al. | Mar 2020 | A1 |
20200069853 | Hall et al. | Mar 2020 | A1 |
20200078223 | Locke et al. | Mar 2020 | A1 |
20200078224 | Carroll et al. | Mar 2020 | A1 |
20200078225 | Grillitsch et al. | Mar 2020 | A1 |
20200078305 | Auvinen et al. | Mar 2020 | A1 |
20200078330 | Gay | Mar 2020 | A1 |
20200078482 | Yoon et al. | Mar 2020 | A1 |
20200078499 | Gadde et al. | Mar 2020 | A1 |
20200085625 | Bellini et al. | Mar 2020 | A1 |
20200085626 | Braga et al. | Mar 2020 | A1 |
20200085629 | Locke et al. | Mar 2020 | A1 |
20200085630 | Robinson et al. | Mar 2020 | A1 |
20200085632 | Locke et al. | Mar 2020 | A1 |
20200085991 | Coomber | Mar 2020 | A1 |
20200085992 | Locke et al. | Mar 2020 | A1 |
20200086014 | Locke et al. | Mar 2020 | A1 |
20200086017 | Jardret et al. | Mar 2020 | A1 |
20200086049 | Park et al. | Mar 2020 | A1 |
20200093646 | Locke et al. | Mar 2020 | A1 |
20200093756 | Sabacinski | Mar 2020 | A1 |
20200093953 | Kim et al. | Mar 2020 | A1 |
20200093954 | Leise, III | Mar 2020 | A1 |
20200093970 | Hunt et al. | Mar 2020 | A1 |
20200095421 | Kettel | Mar 2020 | A1 |
20200100945 | Albert et al. | Apr 2020 | A1 |
20200101192 | Folwarzny | Apr 2020 | A1 |
20200107964 | Locke et al. | Apr 2020 | A1 |
20200107965 | Greener | Apr 2020 | A1 |
20200107966 | Francis | Apr 2020 | A1 |
20200107967 | Holm et al. | Apr 2020 | A1 |
20200108169 | Hu et al. | Apr 2020 | A1 |
20200113741 | Rehbein et al. | Apr 2020 | A1 |
20200114039 | Wang et al. | Apr 2020 | A1 |
20200114040 | Waite et al. | Apr 2020 | A1 |
20200114049 | Wall | Apr 2020 | A1 |
20200121509 | Locke et al. | Apr 2020 | A1 |
20200121510 | Hartwell et al. | Apr 2020 | A1 |
20200121513 | Townsend et al. | Apr 2020 | A1 |
20200121521 | Daniel et al. | Apr 2020 | A1 |
20200121833 | Askem et al. | Apr 2020 | A9 |
20200129338 | Gardiner et al. | Apr 2020 | A1 |
20200129341 | Coulthard et al. | Apr 2020 | A1 |
20200129648 | Drury et al. | Apr 2020 | A1 |
20200129654 | Bouvier et al. | Apr 2020 | A1 |
20200129655 | Gardiner et al. | Apr 2020 | A1 |
20200129675 | Robinson et al. | Apr 2020 | A1 |
20200138754 | Johnson | May 2020 | A1 |
20200139002 | Dudnyk et al. | May 2020 | A1 |
20200139023 | Haggstrom et al. | May 2020 | A1 |
20200139025 | Robinson et al. | May 2020 | A1 |
20200141031 | Kosan et al. | May 2020 | A1 |
20200146894 | Long et al. | May 2020 | A1 |
20200146896 | Rice et al. | May 2020 | A1 |
20200146897 | Locke et al. | May 2020 | A1 |
20200146899 | Pratt et al. | May 2020 | A1 |
20200155355 | Hill et al. | May 2020 | A1 |
20200155358 | Wheldrake | May 2020 | A1 |
20200155359 | Carroll et al. | May 2020 | A1 |
20200155361 | Pigg et al. | May 2020 | A1 |
20200155379 | Shaw et al. | May 2020 | A1 |
20200163802 | Hunt et al. | May 2020 | A1 |
20200163803 | Pigg et al. | May 2020 | A1 |
20200164112 | Kato et al. | May 2020 | A1 |
20200164120 | Jaecklein et al. | May 2020 | A1 |
20200170841 | Waite et al. | Jun 2020 | A1 |
20200170842 | Locke | Jun 2020 | A1 |
20200170843 | Collinson et al. | Jun 2020 | A1 |
20200171197 | Hubbell et al. | Jun 2020 | A1 |
20200179300 | Urban et al. | Jun 2020 | A1 |
20200179558 | Munro et al. | Jun 2020 | A1 |
20200179673 | Wan | Jun 2020 | A1 |
20200188179 | Bugedo-Albizuri et al. | Jun 2020 | A1 |
20200188180 | Akbari et al. | Jun 2020 | A1 |
20200188182 | Sanders et al. | Jun 2020 | A1 |
20200188183 | Hamerslagh et al. | Jun 2020 | A1 |
20200188550 | Dagger et al. | Jun 2020 | A1 |
20200188564 | Dunn | Jun 2020 | A1 |
20200190310 | Meyer | Jun 2020 | A1 |
20200197227 | Locke et al. | Jun 2020 | A1 |
20200197228 | Hartwell | Jun 2020 | A1 |
20200197559 | Bourdillon et al. | Jun 2020 | A1 |
20200197580 | Kilpadi et al. | Jun 2020 | A1 |
20200206035 | Kantor et al. | Jul 2020 | A1 |
20200206036 | Robinson et al. | Jul 2020 | A1 |
20200214637 | Brownhill et al. | Jul 2020 | A1 |
20200214897 | Long et al. | Jul 2020 | A1 |
20200214898 | Waite et al. | Jul 2020 | A1 |
20200214899 | Locke et al. | Jul 2020 | A1 |
20200215220 | Schomburg et al. | Jul 2020 | A1 |
20200215226 | Kitagawa et al. | Jul 2020 | A1 |
20200222469 | Cotton | Jul 2020 | A1 |
20200229983 | Robinson et al. | Jul 2020 | A1 |
20200230283 | Yang et al. | Jul 2020 | A1 |
20200237562 | Rice et al. | Jul 2020 | A1 |
20200237564 | Hammond et al. | Jul 2020 | A1 |
20200237816 | Lait | Jul 2020 | A1 |
20200246190 | Luckemeyer et al. | Aug 2020 | A1 |
20200246191 | Lu et al. | Aug 2020 | A1 |
20200246194 | Gonzalez et al. | Aug 2020 | A1 |
20200246195 | Robinson et al. | Aug 2020 | A1 |
20200253785 | Bernet et al. | Aug 2020 | A1 |
20200253786 | Harrison et al. | Aug 2020 | A1 |
20200253788 | Rehbein et al. | Aug 2020 | A1 |
20200254139 | Phillips et al. | Aug 2020 | A1 |
20200261275 | Manwaring et al. | Aug 2020 | A1 |
20200261276 | Lujan Hernandez et al. | Aug 2020 | A1 |
20200268560 | Harrison et al. | Aug 2020 | A1 |
20200268561 | Locke et al. | Aug 2020 | A1 |
20200269028 | Hegg | Aug 2020 | A1 |
20200270484 | Lipscomb et al. | Aug 2020 | A1 |
20200276055 | Randolph et al. | Sep 2020 | A1 |
20200276058 | Locke et al. | Sep 2020 | A1 |
20200277450 | Silverstein et al. | Sep 2020 | A1 |
20200281519 | Gowans et al. | Sep 2020 | A1 |
20200281529 | Grubb et al. | Sep 2020 | A1 |
20200281678 | Long et al. | Sep 2020 | A1 |
20200281775 | Kushnir et al. | Sep 2020 | A1 |
20200282100 | Gil et al. | Sep 2020 | A1 |
20200282114 | Long et al. | Sep 2020 | A1 |
20200282115 | Gardner et al. | Sep 2020 | A1 |
20200289326 | Nielsen et al. | Sep 2020 | A1 |
20200289327 | Hansen et al. | Sep 2020 | A1 |
20200289328 | Luckemeyer et al. | Sep 2020 | A1 |
20200289346 | Hansen et al. | Sep 2020 | A1 |
20200289347 | Gowans et al. | Sep 2020 | A1 |
20200289701 | Hall et al. | Sep 2020 | A1 |
20200289712 | Jiang et al. | Sep 2020 | A1 |
20200289723 | Gregory et al. | Sep 2020 | A1 |
20200289726 | Locke et al. | Sep 2020 | A1 |
20200289727 | Locke | Sep 2020 | A1 |
20200289806 | Locke et al. | Sep 2020 | A1 |
20200297541 | Hartwell et al. | Sep 2020 | A1 |
20200297543 | Rodzewicz et al. | Sep 2020 | A1 |
20200297544 | Moine et al. | Sep 2020 | A1 |
20200297892 | Silcock | Sep 2020 | A1 |
20200297893 | Ericson | Sep 2020 | A1 |
20200297894 | Koyama et al. | Sep 2020 | A1 |
20200299865 | Bonnefin et al. | Sep 2020 | A1 |
20200306089 | Delury et al. | Oct 2020 | A1 |
20200306091 | Lee et al. | Oct 2020 | A1 |
20200306092 | Rehbein et al. | Oct 2020 | A1 |
20200306094 | Kushnir et al. | Oct 2020 | A1 |
20200306426 | Rice et al. | Oct 2020 | A1 |
20200306428 | Ingram et al. | Oct 2020 | A1 |
20200306430 | Rehbein et al. | Oct 2020 | A1 |
20200315853 | Waite | Oct 2020 | A1 |
20200315854 | Simmons et al. | Oct 2020 | A1 |
20200315894 | Churilla et al. | Oct 2020 | A1 |
20200316271 | Lin | Oct 2020 | A1 |
20200316272 | Simpson | Oct 2020 | A1 |
20200316273 | Hegg | Oct 2020 | A1 |
20200323692 | Locke et al. | Oct 2020 | A1 |
20200324015 | Kettel et al. | Oct 2020 | A1 |
20200330283 | Locke et al. | Oct 2020 | A1 |
20200330284 | Locke et al. | Oct 2020 | A1 |
20200330285 | Rehbein et al. | Oct 2020 | A1 |
20200330658 | Fujisaki | Oct 2020 | A1 |
20200330660 | Patel et al. | Oct 2020 | A1 |
20200337719 | Ingram et al. | Oct 2020 | A1 |
20200337904 | Waite | Oct 2020 | A1 |
20200337905 | Earl et al. | Oct 2020 | A1 |
20200337906 | Long et al. | Oct 2020 | A1 |
20200337908 | Long et al. | Oct 2020 | A1 |
20200338228 | Kharkar et al. | Oct 2020 | A1 |
20200338243 | Harrison et al. | Oct 2020 | A1 |
Number | Date | Country |
---|---|---|
2013366038 | Jul 2015 | AU |
101076251 | Nov 2007 | CN |
101331263 | Dec 2008 | CN |
105407930 | Mar 2016 | CN |
4001690 | Aug 1990 | DE |
0616650 | Sep 1994 | EP |
0680344 | Nov 1995 | EP |
1129730 | Sep 2001 | EP |
1158859 | Dec 2001 | EP |
1318842 | Jun 2003 | EP |
1343510 | Sep 2003 | EP |
1425050 | Jun 2004 | EP |
1557088 | Jul 2005 | EP |
1882482 | Jan 2008 | EP |
1925719 | May 2008 | EP |
1925917 | May 2008 | EP |
1343510 | May 2010 | EP |
2262545 | Dec 2010 | EP |
2935688 | Oct 2015 | EP |
2996730 | Mar 2016 | EP |
3187204 | Jul 2017 | EP |
3241439 | Nov 2017 | EP |
3556407 | Oct 2019 | EP |
3569260 | Nov 2019 | EP |
3643328 | Apr 2020 | EP |
3643330 | Apr 2020 | EP |
3643331 | Apr 2020 | EP |
3669838 | Jun 2020 | EP |
3669843 | Jun 2020 | EP |
3669844 | Jun 2020 | EP |
2604900 | Apr 1988 | FR |
735462 | Aug 1955 | GB |
1105829 | Mar 1968 | GB |
2094802 | Feb 1985 | GB |
2220881 | Jul 1992 | GB |
2579211 | Jun 2020 | GB |
2579368 | Jun 2020 | GB |
S5138427 | Mar 1976 | JP |
H07502081 | Mar 1995 | JP |
H08505790 | Jun 1996 | JP |
2000201976 | Jul 2000 | JP |
2000510539 | Aug 2000 | JP |
2002539140 | Nov 2002 | JP |
2003052725 | Feb 2003 | JP |
2003510475 | Mar 2003 | JP |
2003512095 | Apr 2003 | JP |
2003531828 | Oct 2003 | JP |
2007509034 | Apr 2007 | JP |
2007167266 | Jul 2007 | JP |
2007532606 | Nov 2007 | JP |
2008502735 | Jan 2008 | JP |
2008038293 | Feb 2008 | JP |
2008503557 | Feb 2008 | JP |
2008507327 | Mar 2008 | JP |
2008526997 | Jul 2008 | JP |
2009519312 | May 2009 | JP |
2016040294 | Mar 2016 | JP |
2016519966 | Jul 2016 | JP |
2092180 | Oct 1997 | RU |
9218098 | Oct 1992 | WO |
9312275 | Jun 1993 | WO |
9319152 | Sep 1993 | WO |
9402022 | Feb 1994 | WO |
8401721 | May 1994 | WO |
9416746 | Aug 1994 | WO |
9601119 | Jan 1996 | WO |
9702313 | Jan 1997 | WO |
9606260 | Feb 1998 | WO |
9846818 | Oct 1998 | WO |
0054593 | Sep 2000 | WO |
0072874 | Dec 2000 | WO |
0123653 | Apr 2001 | WO |
0124839 | Apr 2001 | WO |
0128338 | Apr 2001 | WO |
0128600 | Apr 2001 | WO |
0137936 | May 2001 | WO |
0159421 | Aug 2001 | WO |
0162289 | Aug 2001 | WO |
0243743 | Jun 2002 | WO |
02055060 | Jul 2002 | WO |
02078755 | Oct 2002 | WO |
03022317 | Mar 2003 | WO |
03047341 | Jun 2003 | WO |
03068247 | Aug 2003 | WO |
2004028461 | Apr 2004 | WO |
2004035718 | Apr 2004 | WO |
2004056346 | Jul 2004 | WO |
2004108093 | Dec 2004 | WO |
2005018543 | Mar 2005 | WO |
2005020915 | Mar 2005 | WO |
2005032459 | Apr 2005 | WO |
2005079582 | Sep 2005 | WO |
2005099757 | Oct 2005 | WO |
2005123103 | Dec 2005 | WO |
2006000765 | Jan 2006 | WO |
2006015317 | Feb 2006 | WO |
2006022970 | Mar 2006 | WO |
2006029213 | Mar 2006 | WO |
2006111624 | Oct 2006 | WO |
2007005720 | Jan 2007 | WO |
2007068938 | Jun 2007 | WO |
2008035734 | Mar 2008 | WO |
2009130608 | Oct 2009 | WO |
2010070292 | Jun 2010 | WO |
2011121394 | Oct 2011 | WO |
2011135284 | Nov 2011 | WO |
2011144888 | Nov 2011 | WO |
2012061225 | May 2012 | WO |
2012072980 | Jun 2012 | WO |
2012136968 | Oct 2012 | WO |
2013015827 | Jan 2013 | WO |
2013126049 | Aug 2013 | WO |
2014014842 | Jan 2014 | WO |
2014096843 | Jun 2014 | WO |
2014186590 | Nov 2014 | WO |
2015145117 | Oct 2015 | WO |
2015173546 | Nov 2015 | WO |
2016141450 | Sep 2016 | WO |
2017016974 | Feb 2017 | WO |
2017125250 | Jul 2017 | WO |
2018029231 | Feb 2018 | WO |
2018094061 | May 2018 | WO |
2018162613 | Sep 2018 | WO |
2018163093 | Sep 2018 | WO |
2018189265 | Oct 2018 | WO |
2018226667 | Dec 2018 | WO |
2018227144 | Dec 2018 | WO |
2018231825 | Dec 2018 | WO |
2018236648 | Dec 2018 | WO |
2019002085 | Jan 2019 | WO |
2019012068 | Jan 2019 | WO |
2019012069 | Jan 2019 | WO |
2019022493 | Jan 2019 | WO |
2019027933 | Feb 2019 | WO |
2019038548 | Feb 2019 | WO |
2019038549 | Feb 2019 | WO |
2019040656 | Feb 2019 | WO |
2019050855 | Mar 2019 | WO |
2019058373 | Mar 2019 | WO |
2019073326 | Apr 2019 | WO |
2019083563 | May 2019 | WO |
2019083868 | May 2019 | WO |
2019086911 | May 2019 | WO |
2019091150 | May 2019 | WO |
2019094147 | May 2019 | WO |
2019096828 | May 2019 | WO |
2019113275 | Jun 2019 | WO |
2019113623 | Jun 2019 | WO |
2019191590 | Oct 2019 | WO |
2019193141 | Oct 2019 | WO |
2019193333 | Oct 2019 | WO |
2019199389 | Oct 2019 | WO |
2019199596 | Oct 2019 | WO |
2019199687 | Oct 2019 | WO |
2019199798 | Oct 2019 | WO |
2019199849 | Oct 2019 | WO |
2019200035 | Oct 2019 | WO |
2019215572 | Nov 2019 | WO |
2019219613 | Nov 2019 | WO |
2019234365 | Dec 2019 | WO |
2020005062 | Jan 2020 | WO |
2020005344 | Jan 2020 | WO |
2020005536 | Jan 2020 | WO |
2020005546 | Jan 2020 | WO |
2020005577 | Jan 2020 | WO |
2020007429 | Jan 2020 | WO |
2020011691 | Jan 2020 | WO |
2020014178 | Jan 2020 | WO |
2020014310 | Jan 2020 | WO |
2020018300 | Jan 2020 | WO |
2020026061 | Feb 2020 | WO |
2020026144 | Feb 2020 | WO |
2020033351 | Feb 2020 | WO |
2020035811 | Feb 2020 | WO |
2020043665 | Mar 2020 | WO |
2020044237 | Mar 2020 | WO |
2020046443 | Mar 2020 | WO |
2020047255 | Mar 2020 | WO |
2020049038 | Mar 2020 | WO |
2020055945 | Mar 2020 | WO |
2020056014 | Mar 2020 | WO |
2020056182 | Mar 2020 | WO |
2020065531 | Apr 2020 | WO |
2020070231 | Apr 2020 | WO |
2020074512 | Apr 2020 | WO |
2020078993 | Apr 2020 | WO |
2020079009 | Apr 2020 | WO |
2020079330 | Apr 2020 | WO |
2020081259 | Apr 2020 | WO |
2020081391 | Apr 2020 | WO |
2020092598 | May 2020 | WO |
2020136555 | Jul 2020 | WO |
2020141059 | Jul 2020 | WO |
2020144347 | Jul 2020 | WO |
2020150548 | Jul 2020 | WO |
2020159675 | Aug 2020 | WO |
2020159677 | Aug 2020 | WO |
2020159678 | Aug 2020 | WO |
2020159823 | Aug 2020 | WO |
2020159859 | Aug 2020 | WO |
2020159892 | Aug 2020 | WO |
2020161086 | Aug 2020 | WO |
2020173665 | Sep 2020 | WO |
2020173760 | Sep 2020 | WO |
2020174264 | Sep 2020 | WO |
2020174510 | Sep 2020 | WO |
2020182887 | Sep 2020 | WO |
2020185810 | Sep 2020 | WO |
2020197759 | Oct 2020 | WO |
2020197760 | Oct 2020 | WO |
2020198484 | Oct 2020 | WO |
2020201879 | Oct 2020 | WO |
2020213998 | Oct 2020 | WO |
Entry |
---|
Hurlow J, Blanz E, Gaddy J. Clinical investigation of biofilm in non-healing wounds by high resolution microscopy techniques. J Wound Care. 2016; 25(suppl 9): S11-S22. |
India Patent Application No. 9392/DELNP/2013 First Examination Report dated Feb. 23, 2018. |
International Wound Infection Institute (IWII). Wound infection in clinical practice. Wounds International, 2016. http://www.woundinfection-institute.com/wp-content/uploads/2017/03/IWII-Wound-infection-in-clinical-practice.pdf. Accessed Jul. 2, 2018. |
James G, Swogger E, Wolcott R et al. Biofilms in chronic wounds. Wound Repair Regen. 2008; 16: 37-44. |
Japanese Patent Application No. 2017-112806 Official Action dated Mar. 6, 2018. |
Japanese Patent Application No. 2013-541415 Final Rejection dated Jun. 14, 2016. |
Japanese Patent Application No. 2014-242257 Office Action dated Apr. 5, 2016. |
Japanese Patent Application No. 2014-242257 Office Action dated May 23, 2017. |
Japanese Patent Application No. 2014-543972 Office Action dated Dec. 20, 2016. |
Japanese Patent Application No. 2015-200279 Office Action dated Aug. 31, 2017. |
Japanese Patent Application No. 2015-200279 Office Action dated Feb. 7, 2017. |
Japanese Patent Application No. 2015-200279 Office Action dated Jul. 12, 2016. |
Japanese Patent Application No. 2015-548762 Office Action dated Jul. 31, 2018. |
Japanese Patent Application No. 2016-154639 Office Action dated Jun. 8, 2017. |
Japanese Patent Application No. 2016-202835 Office Action dated Jun. 20, 2017. |
Japanese Patent Application No. 2016-202835 Office Action dated Mar. 6, 2018. |
Jasovský D, Littmann J, Zorzet A, Cars O. Antimicrobial resistance—a threat to the world's sustainable development. Upsala J Med Sci. 2016; 121: 159-64. |
Johani K, Malone M, Jensen S et al. Microscopy visualisation confirms multi-species biofilms are ubiquitous in diabetic foot ulcers. Int Wound J. 2017; 14: 1160-9. |
Jones et al., Antimicrobial activity of silver-containing dressings is influenced by dressing conformability with a wound surface. Wounds, 17:263-270 (2005). |
JP-A-H7-504699 (English counterpart WO93/19152). |
JP-A-H7-509236 (English counterpart WO94/02022). |
Kapoor et al., Fluorescence and absorption spectra of Rose-Bengal dye in the presence of surfactants. Journal of Luminescence, 22(4): 429-439, 1981. (Abstract only). |
Kaur et al., Effect of certain chelating agents on the antibacterial action of silver nitrate. Journal of Hygiene, Epidemiology, Microbiology and Immunology. 32(3): 299-306, 1988. |
Keast D, Swanson T, Carville K, Fletcher J, Schultz G, Black J. Ten top tips . . . understanding and managing wound biofilm. Wounds International. 2014; 5: 20-3. |
Kharkevich, D.A., Pharmacology: Textbook. Geotar-Media, p. 66-71, 2006. |
Kim D, Namen W, Moore J, Buchanan M, Hayes V, Myntti M, Hakaim A. Clinical assessment of a biofilm-disrupting agent for the management of chronic wounds compared with standard of care: a therapeutic approach. Wounds. 2018 30: 120-30. |
Kita et al., pH-Dependent preferential antibacterial activity of Ethylenediaminetetraacetic acid (EDTA). Japanese Journal of Bacteriology, 47(4):6 pages, 1992. |
Kite et al., Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol., 42.7 (2004): 3073-3076. |
Kryukov et al., The role of bacteriological examination in diagnosis of chronic tonsillitis. Becthnk 3:35-38, 2008. |
Lazarus G, Cooper D, Knighton D, Percoraro R, Rodeheaver G, Robson M. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994; 2: 165-70. |
Lewis K. Persister cells. Ann Rev Microbiol. 2010; 64: 357-72. |
Lineaweaver et al., Topical antimicrobial toxicity. Arch Surg., 120(3):267-70 (1985). |
Lipsky B, Aragón-Sánchez J, Diggle M et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016; 32: 45-74. |
Lipsky B, Dryden M, Gottrup F et al. Antimicrobial stewardship in wound care: A position paper from the British society for antimicrobial chemotherapy and European wound management association. J. Antimicrob Chemother 2016; 71: 3026-35. |
Lipsky B Medical treatment of diabetic foot infections. Clin Infect Dis. 2004; 39: S104-S114. |
Lipsky B, Peters E, Senneville E et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012; 28(suppl 1): 163-78. |
Macia M, Roho-Molinero E, Oliver A. Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin Microbiol Infect. 2014; 20: 981-90. |
Malone M, Bjarnsholt T, McBain A et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017; 26: 20-5. |
McDonnell G, Russell A. Antiseptics and disinfectants: Activity, action, and resistance. Clin Microbiol Rev. 1999; 12: 147-79. |
Meredith K, Burke N, Brownley H et al. Antimicrobial efficacy of enhanced and standard silver wound dressings in an in vitro mature bioburden model. Symposium on Advanced Wound Care. 2018 Poster presentation: Las Vegas. |
Metcalf D, Bowler P. Biofilm delays wound healing: A review of the evidence. Burns Trauma. 2013; 1; 5-12. |
Metcalf D, Bowler P. Clinical Impact of an enhanced antimicrobial dressing in non-healing wounds previously managed with antibiotics. Symposium on Advanced Wound Care. 2018 Poster presentation: Las Vegas. |
Metcalf D, Bowler P, Parsons D. In: Dhanasekaran D, ed. Wound Biofilm and Therapeutic Strategies, Microbial Biofilms—Importance and Applications. Rijeka, Croatia: InTech; 2016. https://www.intechopen.com/books/microbial-importance-and-applications/wound-biofilm-and-therapeutic-strategies. Accessed Aug. 8, 2018. |
Metcalf D, Parsons D, Bowler P. A next-generation antimicrobial wound dressing: a real-life clinical evaluation in the UK and Ireland. J Wound Care. 2016; 25: 132-8. |
Mexican Patent Application No. MX/a/2013/006090 Official Action dated Jun. 7, 2016. |
Muller et al. pH-dependent formation of ethylenediaminetetraacetic acid supramolecular aggregates. FEBS Lett 340: 17-21 (1994). |
Nagai et al., Suppressive effects of EDTA for Pseudomonas aeruginosa products biofilm STN CAPLUS, Jan. 1, 1996, 1 page. XP002122029. |
Nagoba B, Suryawanshi N, Wadher B, Selkar S. Acidic environment and wound healing: a review. Wounds. 2015; 27: 5-11. |
Newman G, Walker M, Hobot J, Bowler P. Visualisation of bacterial sequestration and bactericidal activity within hydrating Hydrofiber wound dressings. Biomaterials. 2006; 27: 1129-39. |
Nickel J, Wright J, Ruseska I, Marrie T, Whitfield C, Costerton J. Antibiotic resistance of pseudomonas aeruginosa colonizing a urinary catheter in vitro. Eur J Clin Microbiol. 1985; 4: 213-18. |
Nix D, Pierce B, Haugen V. Eliminating non-compliance. In Bryant R and Nix D, eds. Acute and Chronic Wounds Current Management Concepts. 5th ed. St. Louis, MO: Elsevier; 2016: 428-40. |
Nussbaum S, Carter M, Fife C et al. An economic evaluation of the impact, cost, and Medicare policy implications of chronic nonhealing wounds. Value Health. 2018; 21: 27-32. |
Olsen I. Biofilm- specific antibiotic tolerance and resistance. Eur J Clin Microbiol Infect Dis. 2015; 34: 877-86. |
Ono N. A Semi-quantitative measurement of glycocalyx and an ATP bioluminescent assay for the analysis of Pseudomonas Aeruginosa biofilm. The Japanese Journal of Urology, 86(9):1440-1449, 1995. |
Ovington, The Value of Silver in Wound Management. Podiatry Today, Dec. 1999, 12(7):59-62. (marked as Exhibit 3 at the Deposition of Fiona Adam). |
Parikh et al., Antimicrobial silver/sodium carboxymethyl cotton dressings for burn wounds Textile Research Journal, 75 (2):134-138 (2005). |
Parsons et al., Enhanced Performance and Mode of Action of a Novel Antibiofilm Hydrofiber Wound Dressing. BioMed Research International 2016: ID 7616471:1-14 (2016). |
PCT Patent Application No. PCT/GB2012/000329 International Search Report and Written Opinion dated Jul. 17, 2012. |
PCT Patent Application No. PCT/US2014/038224 International Preliminary Report on Patentability dated Nov. 17, 2015. |
PCT Patent Application No. PCT/US2014/038224 International Search Report dated Sep. 15, 2014. |
PCT Patent Application No. PCT/US2014/038224 Written Opinion dated Sep. 15, 2014. |
PCT Patent Application No. PCT/GB2006/004691 International Preliminary Report on Patentability dated Aug. 12, 2008. |
PCT Patent Application No. PCT/GB2006/004691 International Search Report dated Jul. 7, 2008. |
PCT Patent Application No. PCT/GB2006/004691 Written Opinion dated Jul. 7, 2008. |
PCT Patent Application No. PCT/GB2009/002912 International Preliminary Report on Patentability dated Jun. 21, 2011. |
PCT Patent Application No. PCT/GB2009/002912 International Search Report and Written Opinion dated Mar. 2, 2010. |
PCT Patent Application No. PCT/GB2011/001665 International Preliminary Report on Patentability dated Jun. 4, 2013. |
PCT Patent Application No. PCT/GB2011/001665 International Search Report dated Mar. 2, 2012. |
PCT Patent Application No. PCT/GB2011/001665 Written Opinion dated Mar. 2, 2012. |
Pennington JA., A review of iodine toxicity reports. J Am Diet Assoc., 90(11):1571-81 (1990). |
Percival et al., Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm DATA Biosis (online), Jun. 1, 2005, 6 pages XP002485725. |
Percival S, Bowler P. Biofilms and their potential role in wound healing. Wounds. 2004; 16: 234-240. |
Petchiappan A, Chatterji D. Antibiotic resistance: Current perspectives. ACS Omega 2017, 2, 7400-7409. https://www.researchgate.net/publication/321019969/download. Accessed Jul. 7, 2018. |
Phillips T. Chronic cutaneous ulcers: Etiology and epidemiology. J Invest Dermatol. 1994; 102: 38S-41S. |
Poon and Burd, In vitro cytotoxity of silver: implication for clinical wound care. Burns. 30(2):140-7 (2004). |
Ramage et al., Inhibition on Candida albicans bioflim formation using divalent cation chelators (EDTA) Mycopathologia, Kluwer Academic Publishers, 164(6):301-306 (2007). XP019555313. |
Reybrouck et al., Effect of ethylenediamine tetraacetate on the germicidal action of disinfectants against “Pseudomona.” Acta Clinica Belgica, 24(1):32-41, 1969. |
Rhoads D, Wolcott R, Percival S. Biofilms in wounds: management strategies. J Wound Care. 2008; 17: 502-9. |
Rodeheaver G, Ratliff C. Wound cleansing, wound irrigation, wound disinfection. In: Krasner D, van Rijswijk L, eds. Chronic Wound Care: The Essentials e-Book. Malvern, PA: HMP; 2018: 47-62. Available at: https://s3.amazonaws.com/whywoundcare/Files/Chapter+5.pdf. Accessed Jul. 7, 2018. |
Romanelli M, Vowden K, Weir D. Exudate management made easy. Wounds International. 2014. http://www.woundsinternational.com/made-easys/view/exudate-management-made-easy-1. Accessed Jul. 11, 2018. |
Rondas A, Schols J, Stobberingh E, Price P. Definition of infection in chronic wounds by Dutch nursing home physicians. Int Wound J. 2006; 6: 267-74. |
Russian Patent Application No. 2015153446 Office Action and Search Report dated Apr. 23, 2018. |
Russian Patent Application No. 2013129866 Office Action dated Oct. 21, 2016. |
Russian Patent Application No. 2013129866/10 Protocol of a Meeting with the Examiner dated Jun. 14, 2017. |
Russian Patent Application No. 2013149176 Official Action dated Feb. 21, 2018. |
Russian Patent Application No. 2013149176 Official Action dated Jun. 2, 2016. |
Russian Patent Application No. 2015153446 Office Action dated Feb. 10, 2016 (In Russian). |
Said et al., An in vitro test of the efficacy of an anti-biofilm wound dressing. Int J Pharm. 474(1-2):177-181 (2014). |
Saudi Arabia Patent Application No. 515370133 2nd Examination Report dated Feb. 6, 2017. |
Saudi Arabia Patent Application No. 515370133 Examination Report dated Oct. 18, 2016. |
Savage V, Chopra I, ONeill A. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob Agents Chemother. 2013; 57: 1968-70. |
Sen C, Gordillo G, Roy S et al. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 2009; 17: 763-71. |
Senter, A Textbook of Organic Chemistry, Fifth Ed. 1919, pp. 435-443. |
Seth A, Zhong A, Nguyen K et al. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model. Wound Repair Regen. 2014; 22: 712-9. |
Shanmugam V, Couch K, McNish S, Amdur R. Relationship between opioid treatment and rate of healing in chronic wounds. Wound Repair Regen. 2017; 25: 120-30. |
Sharma et al., Toluidine blue-mediated photodynamic effects on Staphylococcal biofilms. Antimicrobial Agents and Chemotherapy, 52(1):299-305, 2008. |
Smith and Nephew, OTC mediation information: Dermal wound cleanser—benzethonium chloride spray Dec. 17, 2009, p. 1-6. XP55031919. |
Song T, Duperthuy M, Nyunt-Wai, S. Sub-optimal treatment of bacterial biofilms. Antibiotics. 2016; 5: 1-18. |
Spellberg B, Srinivasan A, Chambers H. New societal approaches to empowering antibiotic stewardship. JAMA. 2016; 315: 1229-30. |
Stevens D, Bisno A, Chambers H et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014; 59: 147-59. |
Chinese Patent Application No. 201180066375.2 Office Action dated Sep. 26, 2016. |
Chinese Patent Application No. 201180066375.2 Reexamination Decision dated Dec. 20, 2017. |
Chinese Patent Application No. 201280027537.6 Third Office Action dated Mar. 2, 2016. |
Chinese Patent Application No. 201280027537.6 Decision of Reexamination dated Oct. 27, 2017. |
Chinese Patent Application No. 201280027537.6 Office Action dated Sep. 12, 2016. |
Chinese Patent Application No. 201480028155.4 Decision on Rejection dated Nov. 21, 2018. |
Chinese Patent Application No. 201480028155.4 First Office Action dated Apr. 18, 2017. |
Ciofu O, Rojo-Molinero E, Macia M, Oliver A. Antibiotic treatment of biofilm infections. APMIS. 2017; 125:304-19. |
Costerton J, Geesey G, Cheng K. How bacteria stick. Sci Am. 1978; 238:86-95. |
Costerton J, Irvin R, Cheng K. The bacterial glycocalyx in nature and disease. Ann Rev Microbiol. 1981; 35:299-324. |
Costerton J, Stewart P, Greenberg E. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1318-22. |
Costerton JW. Bacterial biofilms in nature and disease. Ann Rev Microbiol. 1987; 41:435-64. |
Database Biosis, Biosciences Information Service, Philadelphia, PA, 1992, Kida N., etaL, Effect of PH on Preferential Antibacterial Activity of Ethylenediaminetetraacetic Acid EDTA, XP002485724, Database Accession No. PREV199294118093. |
Database Biosis, Biosciences Information Service, Philadelphia, PA, 2005, Percival, L, et al.. Effect of PH on Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm, XP002485725, Database Accession No. PREV200600021247. |
Database CA, Chemical Abstracts Service, Columbus, OH, US; Izzat, I.N., et al., Effect of varying concentrations of EDTA on the antimicrobial properties of cutting fluid preservatives, 1979, XP002485722, STN-International Database Accession No. 93:62380. |
Database CA, Chemical Abstracts Service, Columbus, OH, US; Reybrouck, G., et al., Effect of ethylenediaminetetraacetate on the germicidal action of disinfectants against Pseudomonas aeruginosa, XP002485721, STN-International Database Accession No. 72:11588, 1969. |
Database Medline, US National Library of Medicine, Bethesda, MD, 1988, Kaur, P., et al., Effect of certain chelating agents on the antibacterial action of silver nitrate, XP002485723, STN-International Database Accession No. NLM3143759. |
Demidova and Hamblin, Photodynamic therapy targeted to pathogens Int. J. Immunopathol Pharmacol., 17 (3):245-254, 2004. |
Dini V, Salvo P, Janowska A, Di Francesco F, Barbini A, Romanelli M. Correlation between wound temperature obtained with an infrared camera and clinical wound bed score in venous leg ulcers. Wounds. 2015; 27:274-8. |
Dougherty et al., Photodynamic therapy. Journal of the National Cancer Institute, 90(12):889-905, 1998. |
Doughty D, Sparks B. Wound healing physiology and factors that affect the wound repair process. In Bryant R and Nix D, eds. Acute and Chronic Wounds: Current Management Concepts. 5th ed. St. Louis, MO: Elsevier; 2016:63-81. |
Eming S, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med. 2014; 6: 57-72. doi: 10.1126/scitranslmed.3009337. |
Etebu E, Arikekpar I. Antibiotics: Classification and mechanisms of action with emphasis on molecular perspective. Int J of Appl Microbiol and Biothech Res. 2016; 4:90-101. http://www.bluepenjournals.org/ijambr/pdf/2016/October/Etebu_and_Arikekpar.pdf. Accessed Aug. 8, 2018. |
European Centre for Disease Prevention and Control (ECDC). Proposals for EU Guidelines on the Prudent Use of Antimicrobials in Humans. Stockholm: ECDC; 2017. http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b690-af70113dbb90&ID-1643. Accessed Jul. 2, 2018. |
European Patent Application No. 09795521.5 Communication dated Mar. 24, 2017. |
European Patent Application No. 09795521.5 Office Action dated May 9, 2018. |
European Patent Application No. 12719420.7 Communication dated Jul. 20, 2016. |
European Patent Application No. 12719420.7 Examination Report dated Apr. 5, 2017. |
European Patent Application No. 12719420.7 Examination Report dated Aug. 7, 2018. |
European Patent Application No. 14797983.5 Supplementary European Search Report dated Dec. 6, 2016. |
European Patent Application No. 17163418.1 extended European Search Report dated Sep. 17, 2017. |
European Patent Application No. 06820530.1 Communication dated Apr. 7, 2016. |
European Patent Application No. 06820530.1 Communication dated Jan. 30, 2013. |
European Patent Application No. 06820530.1 Communication dated Mar. 30, 2009. |
FDA website on Medical Devices, Premarket Notification (510k), 4 pages, 2013. |
Fife C, Carter M, Walker D, Thomson B. Wound care outcomes and associated cost among patients treated in US outpatient wound centers: Data from the US Wound Registry. Wounds. 2012; 24: 10-7. |
Finnegan S, Percival S. EDTA: an antimicrobial and antibiofilm agent for use in wound care. Adv Wound Care. 2015; 4: 415-21. |
Fleming D, Rumbaugh K. Approaches to dispersing medical biofilms. Microorganisms. 2017; 5: 1-16. |
Frykberg R, Banks J. Challenges in the treatment of chronic wounds. Adv Wound Care. 2015; 4: 560-82. |
Gardner S, Frantz R, Doebbeling B. The validity of the clincal signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen. 2001; 9: 178-86. |
Gardner S, Hillis S, Frantz R. Clinical signs of infection in diabetic foot ulcers with high microbial load. Biol Res Nurs. 2009; 11: 119-28. |
Gilbert, et al., The Use of Poloxamer Hydrogels for the Assessment of Biofilm Suspectibility Towards Biocide Treatments, Journal of Applied Microbiology, 1998, 85: 985-990. |
Gilchrist M, Seaton R. Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists. J Antimicrob Chemother. 2015; 70: 965-70. |
Gottrup F. A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg. 2004; 187: S38-S43. |
Gottrup F, Apelqvist J, Bjarnsholt T et al. Antimicrobials and non-healing wounds: Evidence, controversies and suggestions—key messages. J Wound Care. 2014; 23: 477-8, 480, 482. |
Guest JF, Vowden K. The health economic burden that acute and chronic wounds impose on an average clinical commissioning group/health board in the UK. J Wound Care. 2017; 26: 292-303. |
Harding K, Szczepkowski M, Mikosiński J et al. Safety and performance evaluation of a next-generation antimicrobial dressing in patients with chronic venous leg ulcers. Int Wound J. 2016; 13: 442-8. |
Harrison-Balestra et al., A wound isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol. Surgery, 29(6): 631-635, 2003. |
Hobot et al., Effect of Hydrofiber wound dressings on bacterial ultrastructure. J Electron Microsc (Tokyo). 50(2): 67-75 (2008). |
Howell J, Stair T, Howell A, Mundt D, Falcone A, Peters S. The effect of scrubbing and irrigation with normal saline, povidone iodine, and cefazolin on wound bacterial counts in a Guinea pig model. Am J Emerg Med. 1993; 11: 134-38. |
Stewart P. Antimicrobial tolerance in biofilms. Microbiol Spectrum. 2015; 3: 1-30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507308/pdf/nihms697879.pdf. Accessed Jul. 24, 2018. |
Stotts R. Wound Bioburden. In Baranoski, S, Ayello, E. eds. Wound Care Essentials: Practice and Principles. Philadelphia, PA: Wolters Klower; 2004: 121-48. |
Swisher, R.D., Surfactant effects on humans and other mammals. The Soap and Detergent Association, Scientific and Technical Report, 4:1-8, 11, 16, 17, 19, Nov. 1966. |
Tallardia. Drug synergism: Its detection and applications. The Journal of Pharmacology and Experimental Therapeutics, 298(3):865-872, 2001. |
Thomas and McCubbin, An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. The Journal of Wound Care, Sep. 2003, 12(8):105-108. |
Thomas-Hess, C. Checklist for factors affecting wound healing. Adv Skin Wound Care. 2011; 24: 192. |
Torkington-Stokes R, Metcalf D, Bowler P. Management of diabetic foot ulcers: valuation of case studies. Br J Nurs. 2016; 25: S27-S33. |
Understanding biofilms. Bacteriality. Published online May 26, 2008. http://bacteriality.com/2008/05/biofilm/. Accessed Jul. 2, 2018. |
United Nations. World Population Aging. New York. 2017. http://www.un.org/en/development/desa/population/publications/pdf/ageing/WPA2017_Highlights.pdf. Accessed Jul. 24, 2018. |
U.S. Appl. No. 11/610,671 Office Action dated Apr. 2, 2008. |
U.S. Appl. No. 11/610,671 Office Action dated Apr. 7, 2011. |
U.S. Appl. No. 11/610,671 Office Action dated Aug. 17, 2009. |
U.S. Appl. No. 11/610,671 Office Action dated Dec. 3, 2008. |
U.S. Appl. No. 11/610,671 Office Action dated Feb. 18, 2010. |
U.S. Appl. No. 11/610,671 Office Action dated Mar. 11, 2015. |
U.S. Appl. No. 11/610,671 Office Action dated Mar. 20, 2014. |
U.S. Appl. No. 11/610,671 Office Action dated Oct. 20, 2011. |
U.S. Appl. No. 11/610,671 Office Action dated Oct. 8, 2014. |
U.S. Appl. No. 11/610,671 Office Action dated Sep. 12, 2013. |
U.S. Appl. No. 12/406,316 Office Action dated Apr. 4, 2012. |
U.S. Appl. No. 12/406,316 Office Action dated Apr. 5, 2013. |
U.S. Appl. No. 12/406,316 Office Action dated Aug. 10, 2011. |
U.S. Appl. No. 12/406,316 Office Action dated Nov. 26, 2012. |
U.S. Appl. No. 14/114,517 Office Action dated Aug. 13, 2015. |
U.S. Appl. No. 13/990,755 Office Action dated Jan. 19, 2017. |
U.S. Appl. No. 09/997,545 Office Action dated Feb. 10, 2003. |
U.S. Appl. No. 09/997,545 Office Action dated Jul. 3, 2002. |
U.S. Appl. No. 10/734,784 Office Action dated Apr. 4, 2007. |
U.S. Appl. No. 13/124,472 Office Action dated Feb. 16, 2016. |
U.S. Appl. No. 13/124,472 Office Action dated Jan. 18, 2013. |
U.S. Appl. No. 13/124,472 Office Action dated Jun. 21, 2013. |
U.S. Appl. No. 13/124,472 Office Action dated Jun. 4, 2015. |
U.S. Appl. No. 13/124,472 Office Action dated Oct. 3, 2014. |
U.S. Appl. No. 13/990,755 Office Action dated Jun. 29, 2017. |
U.S. Appl. No. 13/990,755 Office Action dated May 5, 2016. |
U.S. Appl. No. 14/114,517 Office Action dated Apr. 23, 2015. |
U.S. Appl. No. 14/114,517 Office Action dated Mar. 24, 2016. |
U.S. Appl. No. 14/114,517 Office Action dated Oct. 20, 2016. |
U.S. Appl. No. 14/795,176 Office Action dated Feb. 3, 2016. |
U.S. Appl. No. 14/889,818 Office Action dated Jan. 25, 2017. |
Japanese Office Action; Japan Patent Office; Japanese Patent Application No. 2018-223751; dated Sep. 15, 2020; 4 pages. |
PCT/GB2013/053374 International Preliminary Report on Patentability dated Jul. 2, 2015. |
PCT/GB2013/053374 International Search Report dated Jul. 24, 2014. |
PCT/GB2013/053374 Written Opinion dated Jul. 24, 2014. |
PCT/US01/044773 International Search Report dated Aug. 31, 2001. |
PCT/US01/044773 International Preliminary Report on Patentability completed Mar. 10, 2003. |
Chinese Patent Application No. 201380073403.2 First Office Action dated Aug. 16, 2016. |
European Patent Application No. 13821122.2 Communication dated Oct. 25, 2016. |
Australian Patent Application No. 2013366038 Examination Report No. 1 dated Jun. 20, 2017. |
Chinese Patent Application No. 201380073403.2 Office Action dated Jul. 3, 2017. |
Chile Patent Application No. 3274-2015 Second Office Action dated Jan. 22, 2018. |
Japanese Patent Application No. 2016-514095 Office Action dated Feb. 20, 2018. |
U.S. Appl. No. 14/889,818 Office Action dated Jan. 10, 2018. |
Australian Patent Application No. 2013366038 Examination Report No. 2 dated Jun. 19, 2018. |
Australian Patent Application No. 2014265336 Examination Report No. 2 dated Mar. 26, 2018. |
Chinese Patent Application No. 201380073403.2 Third Office Action dated Mar. 26, 2018. |
Chinese Patent Application No. 201480028155.4 Office Action dated Mar. 22, 2018. |
Mexican Patent Application No. MX/a/2015/015197 Office Action dated Mar. 2, 2018. |
Taiwanese Patent Application No. 103117207 Office Action dated Apr. 11, 2018. |
U.S. Appl. No. 14/889,818 Office Action dated Jun. 19, 2018. |
510(k) Premarket Notification, AQUACEL and AQUACEL Ag, Section 5: 510(k) Summary revised Apr. 21, 2008, 6 pages. |
AMR: a major European and Global challenge: fact sheet. Antimicrobial Resistance—European Commission (EC-AMR) 08, Sep. 2017. https://ec.europa.eu/health/amr/sites/amr/files/amr_factsheet_en.pdf. Accessed Jul. 2, 2018. |
Anmar H, Dasgupta M, Costerton J. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother. 1990, 34:2043-2046. |
Arata, J. Staphylococcus aureus and the skin. Japanese Journal of Chemotherapy, 49(3):147-156, 2001. |
Australian Patent Application No. 2014265336 Examiner's First Report dated Mar. 29, 2017. |
Australian Patent Application No. 2017201084 Examination Report No. 1 dated May 18, 2018. |
Banin et al., Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Applied and Environmental Microbiology, 72(3):2064-2069, 2006. |
Bay L, Kragh K, Eickhardt S, et al. Bacterial aggregates establish at the edges of acute epidermal wounds. Adv Wound Care. 2018; 7:105-13. |
Bohn G, Liden B, Schultz G, et al. Ovine-based collagen matrix dressing: Next-generation callagen dressing for wound care. Adv Wound Care. 2016; 5:1-10. |
Bowler et al., Dressing conformability and silver-containing wound dressings. Wounds U.K., 6:14-20 (2010). |
Bowler P. Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections. J Wound Care. 2018 27:273-277. |
Bowler P, Jones S, Davies B, Coyle E. Infection control properties of some wound dressings. J Wound Care. 1999; 8:499-502. |
Bowler P, Jones S, Towers V, et al. Dressing conformability and silver-containing wound dressings. Wounds UK. 2010; 6:14-20. |
Bowler P, Parsons D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine. 2016; 14:6-11. |
Bryant R, Nix D. Principles for practice development to facilitate outcomes and productivity. In Bryant R and Nix D, eds. Acute and Chronic Wounds: Current Management Concepts. 5th ed. St. Louis, MO: Elsvier; 2016:1-20. |
Canadian Patent Application No. 2,834,871 Office Action dated Oct. 1, 2018. |
Canadian Patent Application No. 2,745,059 Office Action dated Apr. 20, 2018. |
Canadian Patent Application No. 2,745,059 Office Action dated Aug. 2, 2017. |
Canadian Patent Application No. 2,745,059 Office Action dated Oct. 25, 2016. |
Canadian Patent Application No. 2,819,303 Office Action dated Oct. 24, 2017. |
Canadian Patent Application No. 2,834,871 Office Action dated Jan. 31, 2018. |
Capinera et al., Insectional activity of photoactive dyes to American and migratory grasshoppers (Orthoptera Acrididae). J. Econ. Entomol., 92(3):662-666, 2000. |
Cavaliere R, Ball J, Turnbull L, Whitchurch C. The biofilm matrix destabilizers, EDTA and DNasel, enhance the susceptibility of nontypeable Hemophilus influenzae biofilms to treatment with ampicillin and ciprofloxacin. Microbiology. 2014; 3:557-67. |
Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States. 2013. http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf. Accessed Aug. 1, 2018. |
Ceri et al., The Calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. Journal of Clinical Microbiology, 37(6):1771-1776, 1999. |
Chan B, Cadarette S, Wodchis W, Wong J, Mittmann N, Kran M. Cost-of-illness studies in chronic ulcers: A systemic review. J Wound Care. 2017; 26:S4-S15. |
Chemburu et al., Light-induced biocidal action of conjugated polyelectrolytes supported on colloids Langmuir, 24:11053-11062 (2008). |
Chile Patent Application No. 3274-2015 Office Action dated Jun. 20, 2017. |
U.S. Appl. No. 14/889,818 Office Action dated Jun. 9, 2017. |
U.S. Appl. No. 14/889,818 Office Action dated Sep. 27, 2016. |
U.S. Appl. No. 13/990,755 Office Action dated Apr. 5, 2018. |
U.S. Appl. No. 15/372,299 Office Action dated Apr. 23, 2018. |
Usacheva et al., Interaction of the photobactericides methylene blue and toluidine blue with a fluorophore in Pseudomonas aeruginosa cells. Lasers in Surgery and Medicine, 40:55-61, 2008. |
Varani et al., Human skin in organ culture and human skin cells (keratinocytes and fibroblasts) in monolayer culture for assessment of chemically induced skin damage. Toxicol Pathol., 35(5):693-701, 2007. |
Vengerovsky, A.I., Pharmaceutical incompatibility. Bulletin of Siberian Medicine, 3:12 pages, 2003. http.7lold.ssmu.ru/bull/03/3/1684.pdf. |
Wainwright. Photodynamic antimicrobial chemotherapy (PACT). Journal of Antimicrobial Chemotherapy, 42:13-28, 1998. |
Wainwright et al., The Use of new methylene blue in Pseudomonas aeruginosa biofilm destruction. Biofueling, 18:247-249, 2002. (Abstract only). |
Walker M, Bowler P, Cochrane C. In vitro studies to show sequestration of matrix metalloprotienases by silver-containing wound care products. Ostomy Wound Manage. 2007; 53: 18-25. |
Walker M, Metcalf D, Parsons D, Bowler P. A real-life clinical evaluation of a next-generation antimicrobial dressing on acute and chronic wounds. J Wound Care. 2015; 24: 11-22. |
Webb R. A chronic case of confusion. J of Wound Care. 2017; 26: 421. |
Welsby S. The Spectrum Activity of AQUACEL Ag+ with Strengthening Fibre Ribbon using an in Vitro Corrected Zone of Inhibition Assay. 2015. ConvaTec data on file. |
White, “An historical overview of the use of silver in wound management,” Actisorb Silver 220, The Silver Supplement Part Two: Clinical Evidence, 6 (Supp. Pt. 2): 6 pages (2001). |
Wilkinson H, Stephenson C, Hardman M. Comparing the effectiveness of polymer debriding devices using a porcine wound biofilm model. Adv Wound Care. 2016; 5: 475-85. |
Wirtanen, G. et al., Performance Evaluation of disinfectant Formulations Using Poloxamer-hydrogel Biofilm-constructs, Journal of Applied Microbiology, 1998, 85:965-971. |
Wolcott R. Biofilms cause chronic infections. J of Wound Care. 2017; 26: 423-5. |
Wolcott R. Disrupting the biofilm matrix improves wound healing outcomes. J Wound Care. 2015; 24: 366-71. |
Wolcott R, Rhoads D. A study of biofilm-based wound management in subjects with critical limb ischemia. J Wound Care. 2008; 17: 145-55. |
Wolcott R, Sanford N, Gabrilska R, Oates J, Wilkinson J, Rumbaugh K. Microbiota is a primary cause of pathogenesis of chronic wounds. J Wound Care. 2016; 25: Sup10: S33-S43. |
Wood et al., Erythrosine is a potential photosensitizer for the photodynamic therapy of oral plaque biofilms. Journal of Antimicrobial Chemotherapy, 57:680-684, 2006. |
Zölß C, Cech JD. Efficacy of a new multifunctional surfactant-based biomaterial dressing with 1% silver sulphadiazine in chronic wounds. Int Wound J. 2016; 13: 738-43. doi: 10.1111/iwj.12361. |
Birttleness, Definition of Brittleness at Dictionary.com, https://www.dictionary.com/browse/brittleness, retrieved Sep. 25, 2019. |
Sawhney, APS et al., Advent of Greige Cotton Non-Wovens Made using a Hydro-Entanglement Process, Textile Research Journal, vol. 80 (15), p. 1540-1549, 2010. |
Australian Examination Report, Australian Patent Office, Australian Patent Application No. 2018204434, dated May 2, 2019, 4 pages. |
Canadian Office Action, Canadian Intellectual Property Office, Canadian Patent Application No. 2,895,896, dated Dec. 13, 2019, 4 pages. |
Japanese Office Action, Japan Patent Office, Japanese Patent Application No. 2018-223751, dated Nov. 5, 2019, 5 pages. |
Number | Date | Country | |
---|---|---|---|
20200299865 A1 | Sep 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14654498 | US | |
Child | 16806255 | US |